AN

Anthony Noble

The Calmer Co International Limited | Non-Executive Director
Dr Noble joined FijiKava. Prior to this he was CEO of Australian Biotherapeutics, a manufacturer of live biotherapeutics based in Coolum Beach, Queensland. Anthony worked at SFI Health and held roles as Managing Director of SFI Research Pty Ltd, as Global Head of Innovation, Group Head of North Asia and as General Manager of the SFI-Shineway Chinese Joint Venture. Anthony was Principal Scientist, for Cryosite Ltd and a lead inspector for the Human Tissue Authority (UK).

Companies and Roles

Company
Title
Tenure
Since
CCO
The Calmer Co International Limited
  • Non-Executive Director
3yrs, 4mthDec 2021
AUK
Aumake Limited
  • Non-Executive Director
1mthFeb 2025

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
AUK
Aumake Limited
28/02/250N/AN/AN/A
CCO
The Calmer Co International Limited
10/12/249,104,7132,666,7492,969,325N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CCO
The Calmer Co International Limited
10/12/24
Issued
4,772,880$0.006$28,637Placement
CCO
The Calmer Co International Limited
10/12/24
Issued
4,772,880$0.006$28,637Placement
CCO
The Calmer Co International Limited
10/12/24
Sell
3,318,167$0.006$19,909On-market trade
CCO
The Calmer Co International Limited
10/12/24
Issued
2,386,440$0.007$16,705Placement
CCO
The Calmer Co International Limited
10/12/24
Sell
3,318,167$0.006$19,909On-market trade